2016, Number 1
<< Back Next >>
Arch Inv Mat Inf 2016; 8 (1)
Perianal lichen sclerosus. Presentation of a case treated with 0.1% tacrolimus ointment
Pérez-Elizondo AD
Language: Spanish
References: 7
Page: 15-17
PDF size: 128.30 Kb.
ABSTRACT
Lichen sclerosus is a chronic inflammatory mucocutaneous of unknown etiology disease. It has been linked with various immunological, genetic, hormonal, infectious and even traumatic factors. It usually occurs in women between the fourth and fifth decades of life and its usual location is the anogenital. Extragenital forms are rare and sit on the trunk, neck and extremities. Because the symptoms it causes in the anogenital area, such as intense itching, dyspareunia, constipation, pain and dysuria altered the quality of life of patients, it is essential to diagnose early and appropriate treatment. It presents a case of perianal LE treated with tacrolimus ointment 0.1%.
REFERENCES
Monsálvez V, Rivera R, Vanaclocha F. Lichen sclerosus, Actas Dermosifiliogr, 2010; 101 (1): 31-38.
Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus, Am J Clin Dermatol, 2013; 14 (1): 27-47.
Vázquez MA, Della-Giovanna P, Cabrera HN, García SM. Liquen escleroso y atrófico. Estudio a propósito de 50 casos, Arch Argent Dermatol, 2001; 51 (2): 47-53.
Weedon D. Disorders of collagen, lichen sclerosus et atrophicus, In: Weedon D. Weedon’s skin pathology, 3rd ed. London: Editorial Elsevier; 2010. pp. 303-329.
Neill SM, Lewis FM, Tatnall FM, Cox NH; British Association of Dermatologists. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010, Br J Dermatol, 2010; 163 (4): 672-682.
Meyrick-Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity. A study of 350 women, Br J Dermatol, 1988; 118 (1): 41-46.
Goldstein AT, Marinoff SC, Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases, J Reprod Med, 2004; 49 (10): 778-780.
Full text